Study Predicts Costs for Brand-Name Drugs Will Continue to Rise
Over a 6-year period, the analysis mapped out drugs cost patterns for the 49 top-selling brand-name medications in the United States based on pharmacy claims data from a health insurance database.
FDA OKs Treatment for Episodic Cluster Headache in Adults
Episodic cluster headaches represent 85% to 90% of cluster headache prevalence, with approximately 250,000 adults living with the condition in the United States.
First Generic Naloxone Nasal Spray is Granted FDA Approval
This approval marks the first generic naloxone nasal spray for use in a community setting by an individual without medical training.
FDA Oks 2-Drug HIV Therapy for Previously Untreated Patients
To be eligible for dolutegravir and lamivudine, patients must have no history of antiretroviral therapy (ART) and no known or suspected substitutions associated with resistance to the individual components of the regimen.
FDA OKs First Short-Course Oral Therapy for Relapsing Forms of MS
THE FDA has approved cladribine (Mavenclad, EMD Serono), a new oral treatment for relapsing forms of multiple sclerosis (MS) in adults including relapsing-remitting disease and active secondary progressive disease.
Dupilumab sBLA Accepted for Severe Chronic Rhinosinusitis with Nasal Polyps Indication
Dupilumab (Dupixent, Regeneron and Sanofi) would be the first FDA-approved biologic for the treatment of severe chronic rhinosinusitis with nasal polyps.
HHS Proposal Focuses On Prescription Drug Rebates
The latest proposed rule, which was announced by Health and Human Services (HHS) Secretary Alex Azar and Inspector General Daniel Levinson, targets backdoor rebates by encouraging manufacturers to pass discounts directly to patients.
Senate Hearing on Drug Prices Addresses Rising Cost of Insulin
According to a recent report, spending on insulin per patient nearly doubled between 2012 and 2016 in the United States, which the researchers determined was largely driven by price hikes.
Generic Vigabatrin Granted FDA Approval for Treatment of Seizures
Officials with the FDA today approved the first generic version of vigabatrin 500-mg tablets, which is also sold under the brand name Sabril, a medication used to treat complex partial seizures.
FDA Approves Treatment for Immune Thrombocytopenia in Pediatric Patients
Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.
CVS, Aetna Finalize Merger with Promise of Innovative Health Care Delivery
CVS Health announced that it has closed its acquisition of Aetna with the promise to transform the consumer health experience.
In Some Patients, Hepatitis C Virus Treatments Can Be Shortened Without Compromising Efficacy
New research suggests that hepatitis C virus treatments can be shortened in half of patients receiving them without compromising efficacy, potentially leading to significant cost savings.
CVS, Aetna Merger Moves Forward
The Department of Justice today granted conditional approval to the $69 billion merger between CVS Health Corporation and Aetna Inc.
Chemotherapy Linked to Functional Decline in Women With Breast Cancer
Older women undergoing chemotherapy for breast cancer have a higher risk of experiencing a decline in their ability to function physically, according to a new study.
FDA Grants Approval to 2 New HIV Treatments
The approvals of Delstrigo and Pifeltro are based on findings from 2 phase 3 clinical trials.
High Alcohol Intake in Adolescence Linked to Aggressiveness of Prostate Cancer Later in Life
Heavy alcohol consumption at an early age may be linked to a 3-fold increased risk of being diagnosed with high-grade prostate cancer, according to a new study.
Life Expectancy Drops, Mortality Rises Among Younger Adults in the United States
US life expectancy rates are dropping, while trends show a surge in young adult and midlife mortality, according to recent studies.
Secondhand Smoke Exposure May Have a Role in Rheumatoid Arthritis Risk
Rheumatoid arthritis the most common type of arthritis, is believed to be triggered by a mix of environmental and genetic factors.
Hepatitis C-Infected Kidneys Can be Safe for Life-Saving Transplants
The benefits of transplanting kidneys from donors with hepatitis C virus (HCV) may outweigh the risks for individuals in need of a lifesaving organ transplant, according to a new study.
Study: Active Substance Shows Promise Against Hepatitis E Virus
Silvestrol, an active substance formed by 400 different types of mahogany plants, may be key to developing a potential cure for hepatitis E virus.
Survey: Patients with Breast Cancer Want Provider Communication to Address Cost Concerns
Advancements in breast cancer treatment have improved survival rates, but financial hardships related to the cost of these lifesaving therapies can weigh heavily on patients.
Diabetes Linked with Higher Risk of Cancer, Greater Likelihood for Women
Diabetes significantly raises the risk of developing cancer, especially in women, according to a newly published study.
Survivors of Cancer in Adolescence, Young Adulthood at Increased Risk for Endocrine Disease
Survivors of cancer in adolescence and young adulthood may be at higher risk for endocrine diseases, such as thyroid disease, testicular dysfunction, and diabetes, according to a recent study published in JAMA.
FDA Approves First Smallpox Treatment to Counter Bioterrorism
FDA Update Warns of Mental Health, Hypoglycemia Risks with Fluoroquinolone
Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances.
Childhood Tonsil and Adenoid Removal Surgery Increases Leaves Long-term Health Risks
Tonsil and adenoid removal surgery during childhood increases the long-term risk of respiratory, allergic, and infectious diseases, according to a recent study.
Antibiotic-Resistant, Hospital-Acquired Infections Rising in Children
Hospital-acquired antibiotic-resistant infection is on the rise among children across the United States, putting those with chronic conditions at higher risk of infection.
Study: Medical Marijuana May Increase Misuse of Prescription Drugs
Recently-published research suggest that medical cannabis use may be associated with a higher risk of abusing prescription medication, including pain relievers.
Drug Treatment Approved for Pediatric Patients with Multiple Sclerosis
Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis (MS) in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.
Study: Wait for Diagnostic Testing May Have an Impact on Cancer Outcomes
Cancer outcomes may be worse for patients with a positive screening result who wait longer for diagnostic testing, according to newly published research.
2 Commerce Drive Cranbury, NJ 08512